Skip to main content
Clinical Trials/ACTRN12623001005640
ACTRN12623001005640
Not yet recruiting
未知

Impact of coeliac plexus neurolysis on pain and quality of life in patients with pancreatic cancer

Royal Brisbane & Women's Hospital0 sites74 target enrollmentSeptember 15, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Pancreatic cancer
Sponsor
Royal Brisbane & Women's Hospital
Enrollment
74
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 15, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients with a confirmed clinical diagnosis of pancreatic cancer
  • Medical documentation and treatment of abdominal pain as established by need for regular opiate use
  • 18 years and over

Exclusion Criteria

  • Advanced disease state that is impacting on capacity to consent
  • Patients who have painless PC not requiring regular opiate medication to treat pain,
  • Elevated INR \> 1\.5
  • Decompensated cardiac failure (NYHA class IV)
  • Decompensated liver failure (Child\-Pugh score B/C)
  • Severe hypotension (sBP\<85mmHg)
  • Currently pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials